Proteolysis at a lysine residue abolishes the recetor-recognition site of α2-Macroglobulin complexes  by Marynen, Peter et al.
Volume 137, number 2 FEBS LETTERS January 1982 
PROTEOLYSIS AT A LYSINE RESIDUE ABOLISHES THE RECEPTOR-RECOGNITION SITE 
OF a,-MACROGLOBULIN COMPLEXES 
Peter MARYNEN, Fred VAN LEUVEN*, Jean-Jacques CASSIMAN and Herman VAN DEN BERGHE 
Division of Human Genetics, Department of Human Biology, University of Leuven, Minderbroedersstraat 12, 3000 Leuven, 
Belgium 
Received 14 December 1981 
1. Introduction 
cwz-Macroglobulin s a unique protease inhibitor in 
the circulation of vertebrates by its steric mode of 
complexation of virtually all endoproteases [11. The 
cYzM-protease complexes are rapidly cleared from 
blood and body fluids by receptor-mediated endocy- 
tosis by fibroblasts [2,3], macrophages [4,5] and 
Kiipffer cells [6]. The receptor is highly discriminative 
and recognizes specifically cwzM-protease complexes 
[3,51. 
more proteolysis of cwzM complexes by trypsin 
abolished both receptor-mediated endocytosis of, and 
antibody binding to, the complexes [ 121. Since this 
proteolysis seemed very limited, further characteriza- 
tion of the receptor-recognition site on azM complexes 
by this approach was indicated [ 121. 
Here, we have examined the proteolysis of cwzM 
complexes, probed by receptor-mediated endocytosis 
and F2B2 antibody binding. The results indicate a 
lysine residue to be involved in both phenomena. 
Reaction with methylamine [7] transforms azM to 
a conformation indistinguishable from that of azM- 
protease complexes, by criteria of rate electrophoresis 
and isoelectric focusing [8]. Furthermore, the meth- 
ylamine-derivative (ol,M . MA) is recognized and 
internalized by fibroblasts [8,9] and macrophages 
[ IO,1 11. The receptor-recognition site is thus part of 
the azM polypeptide chains [8], hence complexes of 
any protease bound to azM will be cleared by recep- 
tor-mediated endocytosis [2]. 
2. Materials and methods 
Endoproteinase Lys-C was from Boehringer. 
Trypsin (TPCK-treated) was from Worthington. 
2,4,6-Trinitrobenzenesulfonate (TNBS) was from 
Sigma. Carrier-free Na rz5 I was from the Radiochemical 
Centre, Amersham. Cyclohexane-1,2-dione was from 
Aldrich. 
To examine the structure recognized by the cellular 
receptor on complexed azM, we have prepared mono- 
clonal antibodies towards methylamine-inactivated 
azM. A hybridoma (F2B2) produced an antibody 
specifically reacting with complexed azM (either pro- 
tease or methylamine generated) thereby preventing 
receptor-mediated endocytosis of the complex [12]. 
Fab portions derived from the antibody (F2B2) were 
equally potent in inhibiting receptor-mediated endo- 
cytosis. This was taken as evidence that the antigenic 
site recognized by the antibody was part of the recep- 
tar-recognition site on the a,M complexes. Further- 
2.1. Receptor-mediirted endocytosis 
Normal human skin fibroblasts (NHF) were cul- 
tured as in [ 131. The purification of ar,M from human 
plasma, the iodination and assay for receptor-mediated 
endocytosis are published procedures [3,8,14]. 
2.2. Derivatization of azM 
Plasma azM was treated with 0.2 M methylamine 
in Tris-HCl(50 mM, pH 8.0) for 3 h at 37°C. The 
protein was isolated by gel filtration (ACA22, Ultrogel, 
LKB). 
* To whom reprint requests should be addressed 
Trinitrobenzoylation of olM . MA was done essen- 
tially as in [ 151, except that NaHCOa buffer (0.1 M) 
was used and 1 mM TNBS. The reaction was followed 
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spectrophotometrically at 367 nM. Reductive methyl- 
ation of azM . MA was done as in [ 16,171. Arginine 
residues were blocked with cyclohexane-1,2dione, as
in [18], in 0.2 M borate buffer (pH 8.5) overnight at 
room temperature. 
2.3. Rate electrophoresis 
Native proteins were examined by rate electropho- 
resis on 5% polyacrylamide gels [8,17]. 
2.4. Trypsin activity 
Enzymatic activity of trypsin was measured spec- 
trophotometrically as in [8]. Benzoyl-arginine- 
p-nitroanilide (BAPNA) was the substrate and activity 
is expressed as increase in absorbance per minute at 
410 nm, pH 8.2 and 37’C. 
3. Results 
3.1. fioteolysis of the receptor-recognition site 
As described, cu?M complexes tored with excess 
free trypsin showed a selective loss of the F2B2 deter- 
minant [ 121. A major drawback for further analysis 
of the proteolytic process was its sluggishness primarily 
because xtensive autodigestion of trypsin occurred 
[ 121. Therefore, we examined conditions under which 
the proteolysis of the receptor-recognition site would 
become amenable to analysis. We preferred to use 
azM-methylamine (ar,M . MA) complexes, to circum- 
vent primary proteolysis of the bait region in arzM- 
protease complexes [ 191. 
Advantage was taken of the well-known effect of 
Ca*+ on the autodigestion of trypsin. a2M - MA was 
incubated at room temperature with 20% (w/w) tryp- 
sin with and without 20 mM Ca*+. Samples, taken 
after different ime intervals (up to 20h), were treated 
with ST1 and examined by rate electrophoresis (5% 
polyacrylamide gels), with and without preincubation 
with the monoclonal antibody F2B2. 
The 02M . MA complexes migrated normally in 
rate electrophoresis, and showed only a minor increase 
in mobility, even after 20 h incubation with trypsin 
(fig.lA). Nevertheless, a progressive loss of F2B2 
determinant had occurred and a complete loss of 
binding was observed in the 20 h sample containing 
Ca*+ (fig.lB). As judged from these gels no extensive 
loss of a2M was apparent, which was confirmed by 
rocket immunoelectrophoresis: 90% or more of the 
original amount of o2M was recovered after 20 h 
incubation in all samples (not shown). 
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Fig.1. Time course of tryptic loss of FZBZ-antigenic site on 
or,M . MA. Effect of calcium. a,M . MA (1 mg/ml) was incu- 
bated with trypsin: (1) at SOrg/ml; (2) at 200 rg/ml; (3) at 
200 pg/ml plus 20 mM CaCl,. The mixtures were buffered at 
pH 8.0 (50 mM Tris-HCI) and kept at 37°C. At the time 
periods indicated, portions (20 pg o,M) were taken and 
either examined (A) directly by rate electrophoresis (5% 
polyacrylamide gels) or (B) incubated with the monoclonal 
antibody F2B2 (30 pg IgC) for 10 min at room temperature 
before rate electrophoresis. The fiist lane in panel B con- 
tained the a,M . MA, prepared as described in the text, not 
treated with trypsin or F2B2. Note the difference in pattern 
of the 20 h samples in panel B: sample (3) (trypsin + Ca2+) 
no longer bound the FZBZ-antibody. The mobility of the 
proteins is indicated at the right and is similar in the following 
figures. 
3.2. Identification of the amino acid residue involved 
The narrow specificity of trypsin for arginine and 
lysine residues allowed us to obtain some information 
on the amino acid residue(s) actually involved in the 
proteolysis of the F2B2 determinant. 
In preliminary experiments, the arginine side chains 
on a2M - MA complexes were derivatized with cyclo- 
hexane-1,2dione [18]. No effect was observed on 
binding of the monoclonal antibody to the derivatives, 
while the loss of the determinant by trypsin proceeded, 
if anything, somewhat faster than on the untreated 
a2M. MAcomplexes (not shown). Receptor-mediated 
endocytosis of these complexes was also unaffected 
(table 1). 
When the lysine residues on 02M . MA were deriv- 
atized (either by trinitrobenzoylation orby reductive 
methylation), binding of the monoclonal antibody to 
these complexes was abolished. The same treatment 
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Table 1 
Effect of derivatization of o,M on binding of monoclonal 
antibody F2B2 and on receptor-mediated endocytosis 
Additions F2B2 Receptor-mediated 
binding endocytosis 
(% inhibition) 
ffIM - 4 
a*M - MA + 59 
or,M . MA-trypsin - 6 
or,M 1 MA-TNB - 9 
or,M . MA-(N,N’)dimethyl - 14 
CQM . MA-CHD + 61 
Normal human fibroblast monolayers were incubated at 37°C 
for 30 min with 50 pg/ml lZsI-labeled a,M . trypsin com- 
plexes in serum-free medium without or with addition of the 
derivatives listed, at 200 pg/ml. Results are expressed relative 
to control (no addition) and are the mean of duplicate deter- 
minations on separate cell layers. Binding of the monoclonal 
antibody F2B2 was examined by rate electrophoresis on 5% 
polyacrylamide gels [ 121. Derivatives of or,M were prepared 
as described in the text: ar,M . MA was either treated with 
20% (w/w) trypsin or derivatized with 2,4,6-trinitrobenzene- 
sulfonate (cu,M . MA-TNB), NaBH, and formaldehyde 
(a,M . MA-(IVfl’)dimethyl) or cyclohexane-1,2dione 
(a,M . MA-CHD). Protein was freed from excess reactant by 
gel filtration 
also affected receptor-mediated ndocytosis (table 1). 
In fact, the very close correlation between ormal 
binding of the monoclonal antibody on the one hand 
and inhibition of receptor-mediated ndocytosis on 
the other [ 121 was considerably extended by these 
findings. 
The extent of derivatization of asM . MAcomplexes 
with trinitrobenzenesulfonate was followed spectro- 
photometrically at 367 nm, while in parallel, the 
derivative was examined by rate electrophoresis on 
5% polyacrylamide gels. Whereas TNBS reacted prac- 
tically immediately with lysine, reaction with 
azM - MA continued for at least 45 min (fig.2A). This 
was accompanied with a progressive increase in elec- 
trophoretic mobility of ol*M . MA (tig.2B) and more 
importantly, with a progressive d crease in binding of 
the monoclonal antibody F2B2. After 75 min reaction 
with TNBS subsequent binding of the antibody was 
nearly completely abolished (fig.2B). 
A further indication of the presence of a lysine- 
residue in the F2B2 determinant was obtained with 
endoproteinase Lys-C, a serine ndoproteinase of bac- 
terial origin specific for lysine residues. This protease 
was very active in provoking proteolytic loss of the 
TIME, min 
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Fig.2. Trinitrobenzoylation of cu,M . MA. (A) a,M . MA was 
derivatized with 2,4,6-trinitrobenzenesulfonate (1 mM final 
cont.) in 0.1 M NaHCO,, at room temperature. The extent of 
reaction was measured spectrophotometrically at 367 nm. 
Two concentrations of or,M . MA were examined: 0.22 mg/ml 
(3 X lo-’ M (a)) and 0.44 mg/ml(6 X lo-’ M (0)). Lysine 
(0.03 mM (0)) was treated with TNBS under similar condi- 
tions. (B)o,M -MA (0.5 mg/ml) in 0.1 M NaHCO, was treated 
with TNBS (1 mM). At the time points indicated, lysine 
(100 mM, pH 8.0) was added (5 mM final cont.) to stop the 
reaction. For the zero time point lysine was added prior to 
TNBS. Rate electrophoresis (5% polyacrylamide gels) of the 
derivatives without (left) and after addition of the mono- 
clonal antibody F2B2 (right) to the same samples, is shown. 
F2B2 determinant on crzM . MA complexes (fig.3). 
Incubation of oZM . MA with endoproteinase Lys-C, 
inhibited with TLCK or aprotinin, did not abolish the 
subsequent formation of F2B2+M . MA complexes. 
4. Discussion 
The proteolytic degradation of the receptor-recog- 
nition site on a*M . methylamine complexes was 
243 
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Fig.3. Proteolytic loss of FZB2determinant by endoprotein- 
ase LysC. ar,M . MA (1 mg/ml) was incubated with endopro- 
teinase LysC (2 mg lyophilisate/ml) in Tris - HCl(50 mM) 
pH 8.0 at 37°C. After 1, 2 and 4 h, the enzyme was inacti- 
vated by addition of TLCK (2 mM final cont.). Control (lane 
denoted by -) was incubated without the enzyme under 
otherwise identical conditions. Rate electrophoresis (5% poly- 
acrylamide gel) is shown for these samples (left) and after 
treatment with the monoclonal antibody F2B2 (right). Note 
the minor increase in mobility of the protease treated 
cr,M . MA, and the practically complete loss of FZBZdeter- 
minant after 4 h incubation. 
probed by a monoclonal antibody and by receptor- 
mediated endocytosis. Trypsin digestion of these 
complexes (in their native conformation without 
denaturation) was very limited, even after prolonged 
incubation. Incubation with Ca’+ accelerated the 
degradation of the receptor-recognition site, probably 
by protecting trypsin towards autodigestion. 
Derivatization of the lysine residues, but not the 
arginine residues, on alM - methylamine blocked 
binding of the monoclonal antibody as well as recep- 
tor-mediated endocytosis. A lysine-specific endopro- 
tease from bacterial origin proved as potent as trypsin 
in degrading the receptor-recognition site. These data 
indicated the presence of at least 1 lysine residue at 
or near the receptor-recognition site. This lysine resi- 
due seemed not abnormally reactive, as a close parallel 
was observed between overall trinitrobenzoylation 
and loss of F2B2 binding. 
These data extend the analogy between the recep- 
tor-recognition site and the F2B2 antigenic determi- 
nant. Both were similarly affected by the different 
modifications, as listed in table 1. This extensive vi- 
dence that the F2B2-antigenic determinant is at least 
part of the receptor-recognition site on arzM complexes 
will allow us to locate this site, along the a,M poly- 
peptide chain. 
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